Today: 11 June 2026
Firefly Aerospace stock steadies in premarket as lawsuit notice puts spotlight back on IPO claims
29 December 2025
1 min read

Firefly Aerospace stock steadies in premarket as lawsuit notice puts spotlight back on IPO claims

NEW YORK, December 29, 2025, 08:00 ET — Premarket

  • Firefly Aerospace shares were little changed ahead of the open after a fresh securities-lawsuit notice
  • Investors are weighing litigation headlines against a softer tone in U.S. equity futures in thin year-end trade
  • Next milestones include a Jan. 12 lead-plaintiff deadline flagged in the notice and this week’s Fed minutes and jobless-claims data

Firefly Aerospace Inc shares edged down 0.1% to $23.34 in premarket trading on Monday.

The muted move keeps attention on the recently listed space-and-defense company as legal headlines circulate into the final, holiday-thinned week of the year, when smaller stocks can swing on limited volume.

U.S. stock index futures were lower early Monday after last week’s records, setting a cautious backdrop for higher-risk names. S&P 500 E-minis were down 0.22% and Nasdaq 100 futures fell 0.40% in premarket trading, Reuters reported.

The Schall Law Firm said in a PR Newswire release early Monday that it had filed a proposed securities class action against Firefly tied to the company’s August 7, 2025 initial public offering and a class period running through Sept. 29, 2025.

The notice said investors seeking to be appointed “lead plaintiff” — typically the investor chosen to steer the litigation on behalf of the broader group — must move by Jan. 12, 2026. PR Newswire

The complaint, as described in the release, alleges Firefly overstated demand and growth prospects for its “Spacecraft Solutions” business and the commercial viability of its Alpha rocket program. PR Newswire

Firefly did not immediately provide a public response in the notice.

The company priced its IPO at $45 per share in August, raising about $868 million, Reuters reported at the time.

Firefly builds launch vehicles and lunar and orbital spacecraft, and has marketed itself as a contractor to national-security, government and commercial customers.

Execution risk has been part of the story. Firefly’s Alpha program has suffered setbacks, and Reuters reported earlier this year that four of six Alpha flights had failed since 2021.

In October, Firefly completed its $855.6 million acquisition of SciTec Innovations, paying $300 million in cash and issuing 11.1 million shares valued at $50 each, a filing showed.

For traders, the near-term question is whether the lawsuit notices broaden into heavier selling pressure or fade in a week dominated by macro headlines and light staffing on trading desks.

On the calendar, investors are watching minutes from the Federal Reserve’s previous meeting and weekly jobless claims, which Reuters flagged as the key U.S. releases in an otherwise data-light week.

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386
Previous Story

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386

MongoDB stock slides as “MongoBleed” exploitation warning puts database security in focus
Next Story

MongoDB stock slides as “MongoBleed” exploitation warning puts database security in focus

Go toTop